Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE:002020)
China
· Delayed Price · Currency is CNY 16.19
+0.83 (5.40%)
Mar 10, 2026, 12:55 PM CST
SHE:002020 Revenue
Zhejiang Jingxin Pharmaceutical had revenue of 1.03B CNY in the quarter ending September 30, 2025, a decrease of -2.57%. This brings the company's revenue in the last twelve months to 4.00B, down -6.63% year-over-year. In the year 2024, Zhejiang Jingxin Pharmaceutical had annual revenue of 4.16B with 3.99% growth.
Revenue (ttm)
4.00B
Revenue Growth
-6.63%
P/S Ratio
3.13
Revenue / Employee
1.03M
Employees
3,869
Market Cap
12.50B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.16B | 159.72M | 3.99% |
| Dec 31, 2023 | 4.00B | 218.99M | 5.79% |
| Jan 1, 2023 | 3.78B | 313.30M | 9.04% |
| Jan 1, 2022 | 3.47B | 208.47M | 6.40% |
| Dec 31, 2020 | 3.26B | -388.61M | -10.66% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Guangdong Taienkang Pharmaceutical | 674.49M |
| Shanghai Haoyuan Chemexpress | 2.87B |
| Shenzhen Chipscreen Biosciences | 909.54M |
| Henan Lingrui Pharmaceutical | 3.78B |
| Beijing Aosaikang Pharmaceutical | 1.83B |
| Zhejiang Hisun Pharmaceutical | 9.84B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 2.72B |
| Zhejiang Hisoar Pharmaceutical | 1.86B |